- Country: Costa Rica
- Summary: 1750 Mg/100 Ml Bismuth Subsalcycilate, Bottle 236 Ml Presentation, Suspension, Oral Administration and Metoxalene 10Mg Capsule Ometaxalene 10Mg Tablet, Administration Via Oral
- CRT Ref No: 121208793
- Deadline: 25 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CRC 7749320
- Notice Type: Tender
- Document Ref. No.: 2025LD-000062-0001102104
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- 1750 mg/100 ml bismuth subsalcycilate, bottle 236 ml presentation, suspension, oral administration and metoxalene 10mg capsule ometaxalene 10mg tablet, administration via oral
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN1750 Mg/100 Ml Bismuth Subsalcycilate, Bottle 236 Ml Presentation, Suspension, Oral Administration and Metoxalene 10Mg Capsule Ometaxalene 10Mg Tablet, Administration Via Oral - Costarica Tender
The COSTA RICAN SOCIAL SECURITY FUND, a Government sector organization in Costa Rica, has announced a new tender for 1750 Mg/100 Ml Bismuth Subsalcycilate, Bottle 236 Ml Presentation, Suspension, Oral Administration and Metoxalene 10Mg Capsule Ometaxalene 10Mg Tablet, Administration Via Oral. This tender is published on CostaricaTenders under CRT Ref No: 121208793 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-25.
The estimated tender value is CRC 7749320, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
